Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Celyad Sa ADR (NQ: CYAD )

0.8780 +0.0107 (+1.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,147
Open 0.8281
Bid (Size) 0.8000 (8)
Ask (Size) 0.8400 (1)
Prev. Close 0.8673
Today's Range 0.8281 - 0.9600
52wk Range 0.4604 - 3.070
Shares Outstanding 22,593,956
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Celyad Oncology appoints Georges Rawadi as its new CEO
From Celyad Oncology SA
Via Globe NewsWire
Celyad Oncology reports full year 2022 financial results and recent business highlights
From Celyad Oncology SA
Via Globe NewsWire

Performance

YTD
+75.60%
+75.60%
1 Month
-23.65%
-23.65%
3 Month
+51.38%
+51.38%
6 Month
-39.45%
-39.45%
1 Year
-60.09%
-60.09%

More News

Read More
Celyad Oncology to announce full year 2022 financial results and host conference call
From Celyad Oncology SA
Via Globe NewsWire
Earnings Scheduled For March 23, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Celyad Oncology announces non-cash impairment
From Celyad Oncology SA
Via Globe NewsWire
REPEAT -- Celyad Oncology SA - Letter to Shareholders
From Celyad Oncology SA
Via Globe NewsWire
Celyad Oncology SA - Letter to Shareholders
From Celyad Oncology SA
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01
From Celyad Oncology SA
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Celyad Oncology provides fourth quarter 2022 business update and 2023 outlook
From Celyad Oncology SA
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.